Skip to content
naulon
Not checkedNot checked for notices yet.

Management of SHDB positive patient with metastatic bilateral giant retroperitoneal paragangliomas

David Strauss, Andres Correa, Yulan Gong and 2 more

Urology Case Reports · 2022

doi:10.1016/j.eucr.2021.101950 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Paragangliomas are rare neuroendocrine tumors that can vary in size and metabolic activity. We report a case of giant bilateral malignant retroperitoneal paragangliomas (PGL) in a patient with germline succinate dehydrogenase B (SDHB) mutation. This patient, who presented in an emaciated and debilitated state, was managed with adrenergic blockade followed by radical primary surgery. After being metabolically and radiographically disease free for 4 years, he underwent salvage resection for recurrent retroperitoneal disease and palliative radiation to a site of solidary vertebral metastasis. We review incidence and prognosis of metastatic PGL.

Abstract licence: CC BY-NC

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.